疏肝

shū gān
  • soothing the liver
疏肝疏肝
疏肝[shū gān]
  1. 其中,疏肝中药组和健脾中药组对GLU和GABA各受体亚单位mRNA的调节作用更好。

    Among them , groups of soothing the liver , invigorating the spleen medicine have a better regulation of GLU and GABA receptor subtypes and mRNA .

  2. 结论:疏肝和胃方通过减少食管组织NOS、VIP含量来治疗混合反流性食管炎。

    Conclusion : Recipe of soothing the liver and regulating the stomach can treat mixed reflux esophagitis through decreasing the content of NOS and VIP in the esophagus tissue .

  3. 疏肝理肺法对应激条件下哮喘大鼠海马糖皮质激素受体mRNA表达的影响

    Effects of Liver-Discharging and Lung-Regulating Therapy on Glucocorticoid Receptor mRNA Expression in Hippocampus of Experimental Asthma Rats

  4. 而乳宁冲剂组、疏肝活血组均可下调肿瘤VEGF蛋白表达;

    The expression of VEGF was dropped in Runing granule preparation group and dispersing liver and promoting blood circulation group .

  5. 将30例P组患者分为两组,一组20例,用疏肝活血健脾方进行治疗;

    P group were divided into two groups , A group , including 20 patients , was treated by the prescription of Smoothing Liver Qi , Acting Blood and strengthening Spleen .

  6. 健脾组和疏肝组大鼠肝组织脂肪变明显减轻,正常组与模型组、健脾组与模型组、疏肝组与模型组比较,肝组织脂肪变程度均有显著性差异(P<0.05)。

    Compared with the model group the degrees of fatty degeneration in treated groups were ameliorated , especially in invigorating spleen group and soothing liver ( P < 0 . 05 ) .

  7. 为观察疏肝健脾法治疗腹泻型肠易激综合征(IBS)的临床疗效。

    To observe the clinical effect of revised Jijiao Lihuang Decoction treating diarrhea IBS .

  8. 疏肝中药对应激小鼠血浆cAMP、cGMP及胸腺细胞凋亡的影响

    Effect of Liver-Soothing Herbal Drugs on Serum cAMP , cGMP Level and Thymus Cell 's Apoptosis in Stressed Mice

  9. 结论:疏肝饮能有效缓解IBS患者的临床症状,提高其生活质量。

    Conclusion : SGY can alleviate the clinical symptoms and improve quality of life of IBS patients .

  10. 方法:门诊提取AIDS合并肝损伤患者78例,采用中医益气活血、健脾疏肝之法配合甘利欣或肝复肽静滴进行治疗。

    Methods : 78 cases of AIDS complicating Hepatic injury were treated with invigorate vital energy to promoting blood flow and invigorating spleen and soothing liver combined diammonium glycyrrhizinate .

  11. 结论:疏肝健脾法干预IGT有较好的临床疗效。

    Conclusions : The Dispersing Stagnated Liver Qi and Strengthening Spleen intervention IGT has better clinical efficacy .

  12. 疏肝调理冲任方联合TE方案治疗乳腺癌患者QOL临床研究

    Clinical Research of Shu Gan Tiao Li Chong Ren Decoction with TE Chemotherapy in the Treatment of Breast Cancer Patients QOL

  13. 祛风化湿健脾疏肝法对肠易激综合征大鼠模型5-HT,VIP水平的影响

    Influences of Dispelling Wind-evil Dissipating Dampness and Strengthening Spleen Soothing Liver for 5-HT and VIP of Diarrhea Irritable Bowel Syndrome Rats

  14. 目的:探讨以疏肝活血法为治则的中药狼疮2号对系统性红斑狼疮(SLE)模型小鼠皮肤雌激素受体(ER)的影响。

    Objective : To explore the effects of Chinese traditional medicine " Lupus II " on estrogen receptors ( ER ) in SLE model mice skin .

  15. 疏肝健脾方药能改善NAFLD模型大鼠肝脂肪变性。

    The soothing liver and invigorating spleen recipes can improve hepatocytes steatosis in rats with NAFLD .

  16. 前言:目的:观察疏肝和胃丸对应激大鼠胃黏膜组织及血清EGFR蛋白表达的影响。

    Objective : To observe the effect of Shugan Hewei Pill on the protein expression of EGFR of the gastric mucosal of rats .

  17. 目的:观察疏肝健脾法对慢性非特异性溃疡性结肠炎(UC)患者的治疗作用。

    To observe the effect of soothing Liver and activating Spleen method ( SLAS ) of TCM in treating ulcerative colitis ( UC ) .

  18. 目的:观察疏肝健脾法治疗纤维肌痛综合征(FMS)的临床疗效。

    Objective : To observe clinical therapeutic effect of the method for soothing the liver and strengthening the spleen on fibromyalgia syndrome ( FMS ) .

  19. LXRa可能是疏肝健脾方药防治NAFLD的一个重要靶点。

    LXR α may an important target for soothing liver and invigorating spleen recipes resistance to the NAFLD .

  20. 用疏肝和胃方治疗后食管组织NOS、VIP含量显著减少,与正常组相比无显著性差异(P>0.05)。

    And they were lowered after treatment . The differences between the treatment groups and the normal group were not notable ( P > 0.05 ) .

  21. 目的:观察疏肝补肾方对肝纤维化大鼠睾丸酮(Te)、促肾上肾皮质激素(ACTH)的调节作用。

    Aim : To observe the regulating effect of decoction shugan Bushen ( SGBS ) on testosterone ( Te ) and adrenocorticotropin ( ACTH ) .

  22. 健脾疏肝解毒方对大鼠肝癌c-myc、p16基因表达影响的研究

    The Study on the Effects of ShuGan JianPi JieDu Recipe on the Causality of Liver Cancer and the Expression of c-myc 、 p16

  23. 用复合因素造成Wistar大白鼠肝纤维化这一被动性动物模型,来观察疏肝理脾片抗肝纤维化的作用。

    The effect of the Shu Gan Li Pi Pian on anti-liver-fibrosis was observed on the animal model , the Wistar rats with liver fibrosis caused by complex factors .

  24. 结论:疏肝健脾法治疗FMS具有较好的临床疗效,对原发性FMS作用尤为明显。

    Conclusion : The method for soothing the liver and strengthening the spleen has a better clinical therapeutic effect on FMS , with more obvious effect on primary FMS .

  25. 结论:中药助孕丸可以通过疏肝益肾降低PRL水平,改善黄体功能,对黄体功能不健型不孕症有明显的治疗作用。

    Conclusion : Zhu Yun Pill could decrease serum PRL , improve luteal phase and treat infertility through dispersing the depressed liver-energy and tonifying kidney .

  26. 目的:观察健脾疏肝方对反流性食管炎大鼠模型食管组织病理及增殖细胞核抗原(PCNA)表达的影响。

    AIM : To investigate the effect of liver-soothing and spleen-strengthening ( LSSS ) decoction on esophageal pathology and proliferating cell nuclear antigen ( PCNA ) expression in rats with reflux esophagitis .

  27. 目的:观察健脾疏肝汤对慢性乙型病毒性肝炎患者病毒指标(HBV-M、HBV-DNA)的影响。

    Objective : To study the effect of Jianpi-Shugan Decoctum in treating the patients with chronic hepatitis B by observing HBV-M , HBV-DNA .

  28. 结论:疏肝中药调整cAMP、cGMP含量,减少胸腺细胞凋亡的发生是其提高免疫功能的重要机制之一。

    Conclusion : LSHD could regulate the content of cAMP and cGMP , reduce the genera - tion of thymus cells ' apoptosis , which is one of the important mechanisms of improving immune function in stressed mice .

  29. 抑制ERK1/2蛋白的表达及磷酸化可能是健脾疏肝方药抗实验性大鼠脂肪肝的机制之一。

    The recipes of invigorating spleen and soothing liver maybe protects against liver injury by reducing the total ERK1 / 2 and activation of ERK1 / 2 in rats fatty liver .

  30. 在血琼脂平板中疏肝和胃丸抗幽门螺杆菌测得MIC为0.0156g/ml生药,其抑菌作用随着药物浓度的增高而增强。

    The minimum inhibitory concentration in above stated plate was 0.0156g/ml . and the anti-bacteria function was increasing with the augment of drug concentration .